Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Total Current Liabilities (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Total Current Liabilities for 15 consecutive years, with $28.7 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 57.32% to $28.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.7 million through Dec 2025, up 57.32% year-over-year, with the annual reading at $28.7 million for FY2025, 57.32% up from the prior year.
  • Total Current Liabilities hit $28.7 million in Q4 2025 for Perspective Therapeutics, up from $20.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $28.7 million in Q4 2025 to a low of $1.8 million in Q3 2021.
  • Historically, Total Current Liabilities has averaged $10.2 million across 5 years, with a median of $8.4 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: surged 402.37% in 2023 and later decreased 26.74% in 2025.
  • Year by year, Total Current Liabilities stood at $1.8 million in 2021, then surged by 69.0% to $3.1 million in 2022, then soared by 402.37% to $15.7 million in 2023, then increased by 16.38% to $18.2 million in 2024, then skyrocketed by 57.32% to $28.7 million in 2025.
  • Business Quant data shows Total Current Liabilities for CATX at $28.7 million in Q4 2025, $20.6 million in Q3 2025, and $13.0 million in Q2 2025.